Vanda Pharmaceuticals
VNDA
#7861
Rank
โ‚น28.61 B
Marketcap
โ‚น484.22
Share price
3.65%
Change (1 day)
19.62%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚น10.47 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.21 Billion. In 2024 the company made an earning of -โ‚น3.66 Billion a decrease over its 2023 earnings that were of -โ‚น1.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น10.47 Billion186.58%
2024 -โ‚น3.66 Billion191.43%
2023 -โ‚น1.26 Billion-320.45%
2022 โ‚น0.56 B-84.99%
2021 โ‚น3.78 B54.8%
2020 โ‚น2.44 B19.42%
2019 โ‚น2.04 B4.93%
2018 โ‚น1.95 B-228.6%
2017 -โ‚น1.52 Billion-8.98%
2016 -โ‚น1.67 Billion-53.79%
2015 -โ‚น3.62 Billion-30.18%
2014 -โ‚น5.18 Billion173.08%
2013 -โ‚น1.9 Billion-25.33%
2012 -โ‚น2.54 Billion163.61%
2011 -โ‚น0.97 Billion-221.15%
2010 โ‚น0.79 B-124.53%
2009 -โ‚น3.24 Billion-29.44%
2008 -โ‚น4.59 Billion-36.2%
2007 -โ‚น7.2 Billion21.81%
2006 -โ‚น5.91 Billion170.55%
2005 -โ‚น2.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.475 T-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น2.021 T-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.910 T-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น721.65 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.064 T-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚น0.26 Billion-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.074 T-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA